Skip to main content

AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th

The global "AI in drug discovery" market is expected to expand by a CAGR of 30% between now and 2030 and lead to approximately 50 novel therapies being brought to market over the next decade, with annual sales in excess of $50 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.